HealthNews Pulse
AI drug firm Pathos raises $237 million, pushing valuation to $3 billion
AI drug firm Pathos raises $237 million, a deal that brings together a big Tempus dataset, AI analysis from Pathos, and drug development from BMS.
Read the full pulseContinue in Briflio to read, react, comment, and share.
Sources